Talbot Financial’s Boston Scientific BSX Stock Holding History

Talbot Financial’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,019	Closed	-$217K	–	68
2025 Q2	$217K	Hold	2,019	–	–	0.02%	62
2025 Q1	$204K	Buy	+2,019	New	+$203K	0.03%	62

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Talbot Financial's BSX Position: Q3 2025 in Review

Talbot Financial sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 2,019 shares — an estimated $217K sold.

Talbot Financial first reported a position in BSX in Q1 2025 and held it in 2 quarters. The position peaked at $217K in Q2 2025. 1,712 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

Talbot Financial reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
Talbot Financial sold 2,019 Boston Scientific shares in Q3 2025, an estimated $217K.
Talbot Financial first reported a position in Boston Scientific in Q1 2025 and held it in 2 quarters.
Talbot Financial's Boston Scientific position peaked at $217K in Q2 2025.
1,712 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Talbot Financial's 13F filing for Q3 2025, filed 8 Oct 2025.